BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 139 found
  Current Search:  actos: 139     

HTML
100%
FDA panel urges more testing for diabetes drugs
WASHINGTON - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration...

QC Times:  Jul 6 2008 11:30AM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
WASHINGTON Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration voted...

Centre Daily Times:  Jul 6 2008 5:25AM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
WASHINGTON - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration...

Casper Star Tribune:  Jul 5 2008 6:04PM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
Story highlightsDiabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

WASHINGTON Diabetes drugs should face tougher...

Beaufort Gazette:  Jul 5 2008 2:50PM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
WASHINGTON - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration...

QC Times:  Jul 5 2008 12:15PM
Matching: actos
Find similar documents
HTML
100%
Statins Found to Affect Glial Progenitor Cells
Statins affect glial progenitor cells, which are important to brain health as we age, according to a group of scientists.

These cells are similar to stem cells and can become either astrocytes or oligodendrocytes.

The researchers found,...

Genetic Engineering News:  Jul 5 2008 5:08AM
Matching: actos
Find similar documents
HTML
100%
Statins Have Unexpected Effect On Pool Of Powerful Brain Cells
Cholesterol-lowering drugs known as statins have a profound effect on an elite group of cells important to brain health as we age, scientists at the University of Rochester Medical Center have found.

The new findings shed light on a long...

Science Daily:  Jul 5 2008 2:49AM
Matching: actos
Find similar documents
HTML
100%
FDA urges stringent standards for diabetes drugs
WASHINGTON - Diabetes drugs would be subject to more stringent safety standards that could cost manufacturers millions, under recommendations made Wednesday by a U.S.

government panel.

Advisers to the Food and Drug Administration voted...

C-Health:  Jul 4 2008 10:13PM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
WASHINGTON - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.Advisers to the Food and Drug Administration voted...
NWI Times:  Jul 4 2008 7:03AM
Matching: actos
Find similar documents
HTML
100%
FDA Panel Urges More Testing for Diabetes Drugs
WASHINGTON (AP) -- Diabetes drugs would be subject to more stringent safety standards that could cost manufacturers millions, under recommendations made Wednesday by a government panel.

Advisers to the Food and Drug Administration voted 14...

InteliHealth:  Jul 4 2008 6:11AM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
WASHINGTON - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration...

QC Times:  Jul 4 2008 6:06AM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration voted 14-2 on...

KMSP-TV:  Jul 4 2008 4:13AM
Matching: actos
Find similar documents
HTML
100%
FDA: Diabetes Drugs Should Face Tougher Standards
Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration voted 14-2 on...

FOXNews.com:  Jul 4 2008 3:17AM
Matching: actos
Find similar documents
HTML
100%
Diabetes-drug testing pushed
WASHINGTON - Diabetes drugs should face tougher safety standards that could cost manufacturers millions, but protect patients from unforeseen heart risks, a government panel recommended.

The Food and Drug Administration advisory panel...

Philly.com:  Jul 4 2008 2:52AM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
WASHINGTON - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration...

Minneapolis Star Tribune:  Jul 4 2008 1:59AM
Matching: actos
Find similar documents
HTML
100%
Statins Found to Affect Glial Progenitor Cells
Statins affect glial progenitor cells, which are important to brain health as we age, according to a group of scientists.

These cells are similar to stem cells and can become either astrocytes or oligodendrocytes.

The researchers found,...

Genetic Engineering News:  Jul 4 2008 1:45AM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration voted 14-2 on...

Fox 2 KASA:  Jul 4 2008 1:04AM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
WASHINGTON Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration voted...

Savannah Morning News:  Jul 4 2008 12:22AM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration voted 14-2 on...

Seattle Times:  Jul 3 2008 10:23PM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration voted 14-2 on...

FOX 10 WALA:  Jul 3 2008 8:10PM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration voted 14-2 on...

FOX WTTG Washington:  Jul 3 2008 7:53PM
Matching: actos
Find similar documents
HTML
100%
FDA Advisers Call for Cardiovascular-Safety Assessment of New Diabetes Drugs
ROCKVILLE, Md., July 3 -- Type 2 diabetes drugs aiming to pass FDA muster should be required to consider long-term cardiovascular safety as part of the approval mix, according to agency advisers.

The Endocrinologic and Metabolic Drugs...

MedPage Today:  Jul 3 2008 6:01PM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
WASHINGTON - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.Advisers to the Food and Drug Administration voted...
NWI Times:  Jul 3 2008 5:35PM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more stringent safety standards for diabetes drugs
Diabetes drugs would be subject to more stringent safety standards that could cost manufacturers millions, under recommendations made Wednesday by a U.S.

government panel.

Advisers to the Food and Drug Administration voted 14-2 that all...

Yahoo! Canada:  Jul 3 2008 5:33PM
Matching: actos
Find similar documents
HTML
100%
FDA panel urges more testing for diabetes drugs
(AP) WASHINGTON - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Advisers to the Food and Drug Administration...

WNYT:  Jul 3 2008 4:36PM
Matching: actos
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.